• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Acquisition of mixed lineage leukemia rearrangement in a chronic myeloid leukemia patient while on imatinib.

作者信息

Zámečníkova Adriana

机构信息

Kuwait Cancer Control Center, Department of Hematology, Kuwait.

出版信息

Hematol Rep. 2011 Aug 31;3(2):e13. doi: 10.4081/hr.2011.e13.

DOI:10.4081/hr.2011.e13
PMID:22184534
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3238483/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2109/3238483/21415a087253/hr-2011-2-e13-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2109/3238483/21415a087253/hr-2011-2-e13-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2109/3238483/21415a087253/hr-2011-2-e13-g001.jpg

相似文献

1
Acquisition of mixed lineage leukemia rearrangement in a chronic myeloid leukemia patient while on imatinib.一名慢性髓性白血病患者在接受伊马替尼治疗期间出现混合谱系白血病重排。
Hematol Rep. 2011 Aug 31;3(2):e13. doi: 10.4081/hr.2011.e13.
2
Dasatinib: from treatment of imatinib-resistant or -intolerant patients with chronic myeloid leukemia to treatment of patients with newly diagnosed chronic phase chronic myeloid leukemia.达沙替尼：从治疗对伊马替尼耐药或不耐受的慢性髓性白血病患者到治疗新诊断的慢性期慢性髓性白血病患者。
Clin Ther. 2012 Feb;34(2):272-81. doi: 10.1016/j.clinthera.2012.01.009. Epub 2012 Jan 27.
3
Double and single mixed-lineage leukemia-rearranged subclones in pediatric acute myeloid leukemia: a case report.儿童急性髓系白血病中双和单混合谱系白血病重排亚克隆：一例报告。
J Med Case Rep. 2021 May 7;15(1):228. doi: 10.1186/s13256-021-02841-2.
4
B-Cell Chronic Lymphocytic Leukemia with 11q22.3 Rearrangement in Patient with Chronic Myeloid Leukemia Treated with Imatinib.伊马替尼治疗的慢性髓性白血病患者中伴有11q22.3重排的B细胞慢性淋巴细胞白血病
Case Rep Med. 2016;2016:9806515. doi: 10.1155/2016/9806515. Epub 2016 Mar 3.
5
Rearrangement of PDGFRβ gene in a patient with Ph-negative chronic myeloid leukemia t(5;12)(q33;p13) in imatinib mesylate treatment-free remission: a case report.甲磺酸伊马替尼治疗后处于无治疗缓解期的Ph阴性慢性髓性白血病t(5;12)(q33;p13)患者中PDGFRβ基因重排：一例报告
Int J Clin Exp Pathol. 2019 Jun 1;12(6):2284-2287. eCollection 2019.
6
Chronic myeloid leukemia in chronic phase responding to imatinib: the occurrence of additional cytogenetic abnormalities predicts disease progression.慢性期慢性髓性白血病对伊马替尼有反应：出现额外的细胞遗传学异常预示疾病进展。
Haematologica. 2003 Mar;88(3):260-7.
7
Incidence of MLL rearrangement in acute myeloid leukemia, and a CALM-AF10 fusion in M4 type acute myeloblastic leukemia.急性髓系白血病中MLL重排的发生率，以及M4型急性髓性白血病中的CALM-AF10融合。
Leuk Lymphoma. 2002 Jan;43(1):89-95. doi: 10.1080/10428190290000437.
8
U.S. Food and Drug Administration Drug Approval Summary: conversion of imatinib mesylate (STI571; Gleevec) tablets from accelerated approval to full approval.美国食品药品监督管理局药品批准总结：甲磺酸伊马替尼（STI571；格列卫）片剂从加速批准转为完全批准。
Clin Cancer Res. 2005 Jan 1;11(1):12-9.
9
Neferine in the Lotus Plumule Potentiates the Antitumor Effect of Imatinib in Primary Chronic Myeloid Leukemia Cells In Vitro.荷叶铁线蕨中的莲心碱增强伊马替尼在体外对慢性髓性白血病原代细胞的抗肿瘤作用。
J Food Sci. 2019 Apr;84(4):904-910. doi: 10.1111/1750-3841.14484. Epub 2019 Mar 13.
10
Spotlight on dasatinib in chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia.聚焦达沙替尼在慢性髓性白血病和费城染色体阳性急性淋巴细胞白血病中的应用。
BioDrugs. 2012 Feb 1;26(1):61-4. doi: 10.2165/11207640-000000000-00000.

引用本文的文献

1
Leukemogenic rearrangements at the mixed lineage leukemia gene (MLL)-multiple rather than a single mechanism.混合谱系白血病基因（MLL）的白血病发生重排——多种而非单一机制。
Front Cell Dev Biol. 2015 Jun 25;3:41. doi: 10.3389/fcell.2015.00041. eCollection 2015.
2
Chromosomal rearrangement involving 11q23 locus in chronic myelogenous leukemia: a rare phenomenon frequently associated with disease progression and poor prognosis.慢性粒细胞白血病中涉及11q23位点的染色体重排：一种罕见现象，常与疾病进展和预后不良相关。
J Hematol Oncol. 2015 Apr 8;8:32. doi: 10.1186/s13045-015-0128-2.

本文引用的文献

1
Additional t(1;11)(q21;q23) with mixed lineage leukemia rearrangement in T-blastic crisis of a Ph-positive chronic myeloid leukemia.伴有混合谱系白血病重排的额外t(1;11)(q21;q23)见于1例Ph阳性慢性髓性白血病急淋变患者。
Eur J Haematol. 2007 Aug;79(2):179-81. doi: 10.1111/j.1600-0609.2007.00884.x. Epub 2007 Jul 2.
2
Uncommon karyotypic abnormality, t(11;19)(q23;p13.3), in a patient with blastic phase of chronic myeloid leukemia.一名慢性髓性白血病急变期患者出现罕见的核型异常，t(11;19)(q23;p13.3) 。
Cancer Genet Cytogenet. 2004 Apr 15;150(2):159-63. doi: 10.1016/j.cancergencyto.2003.09.005.
3
Simultaneous occurrence of a t(9;22) (Ph) with a t(2;11) in a patient with CML and emergence of a new clone with the t(2;11) alone after imatinib mesylate treatment.
一名慢性粒细胞白血病（CML）患者同时出现t(9;22)（费城染色体）和t(2;11)，且在甲磺酸伊马替尼治疗后出现仅带有t(2;11)的新克隆。
Leukemia. 2003 Apr;17(4):807-10. doi: 10.1038/sj.leu.2402877.
4
Multicolor COBRA-FISH analysis of chronic myeloid leukemia reveals novel cryptic balanced translocations during disease progression.慢性髓性白血病的多色COBRA-FISH分析揭示了疾病进展过程中新型隐匿性平衡易位。
Genes Chromosomes Cancer. 2002 Oct;35(2):127-37. doi: 10.1002/gcc.10099.
5
Additional t(11;17)(q23;q21) in a patient with Philadelphia-positive mixed lineage antigen-expressing leukemia.一名费城染色体阳性且表达混合谱系抗原的白血病患者出现额外的t(11;17)(q23;q21)。
Cancer Genet Cytogenet. 2001 Apr 1;126(1):8-12. doi: 10.1016/s0165-4608(00)00382-4.
6
A carboxy-terminal domain of ELL is required and sufficient for immortalization of myeloid progenitors by MLL-ELL.ELL的羧基末端结构域对于MLL-ELL使髓系祖细胞永生化而言是必需且足够的。
Blood. 2000 Dec 1;96(12):3887-93.
7
Retrovirus-mediated gene transfer of MLL-ELL transforms primary myeloid progenitors and causes acute myeloid leukemias in mice.逆转录病毒介导的MLL-ELL基因转移可转化原代髓系祖细胞并在小鼠中引发急性髓系白血病。
Proc Natl Acad Sci U S A. 2000 Sep 26;97(20):10984-9. doi: 10.1073/pnas.190167297.
8
The translocations, t(11;19)(q23;p13.1) and t(11;19)(q23;p13.3): a cytogenetic and clinical profile of 53 patients. European 11q23 Workshop participants.易位，t(11;19)(q23;p13.1)和t(11;19)(q23;p13.3)：53例患者的细胞遗传学和临床特征。欧洲11q23研讨会参与者。
Leukemia. 1998 May;12(5):805-10. doi: 10.1038/sj.leu.2401016.